iCAD's Breast AI Suite Empowers Customers to Lead the Way in Support of FDA's National Breast Density Reporting StandardGlobeNewsWire • 03/23/23
iCAD Previews Fourth Quarter Financial Results, Full Report on March 28, 2023GlobeNewsWire • 03/13/23
New Real-World Clinical Evidence Confirms ProFound AI Boosts Radiologists' Efficiency and AccuracyGlobeNewsWire • 03/01/23
iCAD Announces CFO Transition and Hires New Senior Vice President, US Commercial Sales, AIGlobeNewsWire • 01/23/23
iCAD features Solis Mammography in upcoming “ProFound Insights, ProFound Impact” webinarGlobeNewsWire • 12/08/22
Positive New Research Presented at RSNA 2022 Reaffirms iCAD's Breast AI Suite Improves Radiologists' Performance and Breast Cancer DetectionGlobeNewsWire • 11/21/22
iCAD to Join Forces with Radiology Partners, the Nation's Largest Radiology PracticeGlobeNewsWire • 11/10/22
iCAD Customers in the U.S. and Europe Increasingly Adopting Company's Full Suite of Breast AI Technologies via Subscription ModelGlobeNewsWire • 08/29/22
After Plunging 29.6% in 4 Weeks, Here's Why the Trend Might Reverse for Icad (ICAD)Zacks Investment Research • 08/19/22
iCAD, Inc. (ICAD) CEO Stacey Stevens on Q2 2022 Results - Earnings Call TranscriptSeeking Alpha • 08/11/22
iCAD Presents its Complete Suite of Breast Cancer AI Solutions at the European Congress of RadiologyGlobeNewsWire • 07/13/22